LIMINATUS PHARMA INC.
Q2 2025 13F Holders
Symbol
LIMN
CUSIP
53271X108
Type
Equity
Class
CL A
Num filers
10
Total reported value, excl. options
$2.31 M
Compare 2025 Q2 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
Manager
Report Date
Value ($000)
Shares
Option Type